Adamax vs Selank
Adamax (Semax analogue with adamantane modification) and Selank are both heptapeptide-derived neuropeptide research compounds, but target different pathways.
Research Use Only
Comparison information is provided for in-vitro research reference only. Orion compounds are not FDA-approved and are not for human consumption.
| Adamax | Selank | |
|---|---|---|
| CAS Number | Research | 129954-34-3 |
| Molecular Weight | — | 751.87 g/mol |
| Sequence | — | TKPRPGP |
| Purity (spec) | 99.1% | 99.3% |
| Size | 5mg | 10mg |
| Half-Life (lit.) | — | 9 min (lit. 0.08h–0.3h) |
| Single price | $24.99 | $34.99 |
| 10-pack/vial | $18.74 | $26.24 |
| In stock? | Yes | Yes |
Neuropeptide Research
Adamax
Modified Semax analogue with adamantane moiety. Enhanced stability profile. 5mg starter vial.
Neuropeptide Research
Selank
Synthetic analogue of tuftsin. Heptapeptide research compound. 10mg research vial.
FAQ
What's the chemical difference between Adamax and Selank?
Adamax (CAS Research) and Selank (CAS 129954-34-3, MW 751.87 g/mol) are distinct compounds. Adamax (Semax analogue with adamantane modification) and Selank are both heptapeptide-derived neuropeptide research compounds, but target different pathways.
Which is more commonly used in research?
Both Adamax and Selank appear extensively in Neuropeptide research compounds literature. Comparative-mechanism studies frequently use them as paired references. Selection between them depends on the receptor coverage, kinetics, and assay system of the planned experiment.
What purity does Orion ship for each?
Adamax ships at 99.1%. Selank ships at 99.3%. Each batch is independently tested by reversed-phase HPLC and confirmed by mass spectrometry against the theoretical molecular weight. Every order ships with a batch-specific Certificate of Analysis.
Are these for human use?
No. All Orion research compounds are for in-vitro laboratory research only. They are not FDA-approved for any therapeutic, diagnostic, or clinical use, and they are not for human consumption.